National HealthNHI.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, National Health (NHI.N) trades at a P/E of 19.50x, P/B of 2.06x, P/S of 7.53x, and a dividend yield of 4.20%.
Longitudinal percentile comparison: P/E sits at the 28th percentile over the trailing 10Y window (vs. 10th percentile over 3Y); P/B sits at the 37th percentile over the trailing 10Y window (vs. 16th percentile over 3Y); P/S sits at the 8th percentile over the trailing 10Y window (vs. 9th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 60th percentile within its industry and the 51st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 4.20%, ranking at the 4th percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 8.9 points of each other — a consistent signal from both angles. The P/E percentile sits lower across the market than within its own industry — relatively cheaper next to the market as a whole. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. National Health operates in the Finance, Insurance, And Real Estate sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: NHI · NHI
Want the full picture on whether National Health (NHI.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 19.50 | ||||||
| P/B (MRQ) | 2.06 | ||||||
| P/S (TTM) | 7.53 | ||||||
| Dividend Yield | 4.20% | ||||||
| Buyback + Div Yield | 4.20% |